ArticleJournal of acquired immune deficiency syndromes (1999)2026
Frailty and All-Cause Mortality Among People With HIV Engaged in Clinical Care in the United States.
Article in Journal of acquired immune deficiency syndromes (1999), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between housing instability and frailty among people with HIV.AIDS (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundFrailty occurs at younger ages among people with HIV (PWH) than those without HIV, but its impact on mortality is unknown.
methodsWe examined the association between frailty (defined by a validated phenotype including inactivity, fatigue, weight loss, and immobility) and mortality (ascertained from state and national death data) among PWH in the Centers for AIDS Research Network of Integrated Clinical Systems cohort between January 2015 and March 2024 using adjusted Cox proportional hazards models.
resultsAmong 6750 PWH in this study, the average age was 50 years, 15% were female, 44% were prefrail, 11% were frail at baseline, and the incidence of frailty was 9.7 per 1000 person-years [95% Confidence Interval (CI):8.8 to 10.8] over an average of 5.5 years of follow-up. In adjusted models, frailty was associated with 2.7-times (95% CI: 2.0 to 3.6), and prefrailty with 1.5-times (95% CI: 1.2 to 2.0), higher risk of mortality. Prefrailty and frailty were consistently associated with an increased risk of death in models stratified by age (<50 vs. ≥50) and sex (male vs. female). Frailty was associated with 3.6-times (95% CI: 2.2 to 6.1) and 2.5-times (95% CI: 1.7 to 3.5) higher risk of mortality among PWH younger than 50 years and 50 years and older, respectively, and with 2.6-times (95% CI: 1.9 to 3.6) and 3.9-times (95% CI: 1.7 to 8.9) higher risk among male and female PWH, respectively.
conclusionsIn a large cohort of PWH, frailty and prefrailty were associated with a greater risk of death among PWH of all ages. Preventing frailty in this high-risk population is an important public health priority.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.